XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Jun. 30, 2018
Current assets    
Cash and cash equivalents $ 17,804,887 $ 7,012,527
Restricted cash 100,225 100,000
Accounts receivable, net 1,482,490 578,782
Inventory, net 1,644,861 1,338,973
Prepaid expenses and other 944,766 440,009
Total current assets 21,977,229 9,470,291
Fixed assets, net 186,944 218,684
Licensed assets, net 19,999,550 11,120,086
Patents, net 233,278 245,944
Deposits 2,200 5,088
Total long-term assets 20,421,972 11,589,802
Total assets 42,399,201 21,060,093
Current liabilities    
Accounts payable and other 2,371,785 2,119,672
Accrued liabilities 932,690 185,882
Accrued compensation 743,834 540,674
 Current deferred revenue 13,990 0
Current deferred rent 0 1,450
Current contingent consideration 593,173 547,100
Total current liabilities 4,655,472 3,394,778
Long-term contingent consideration 12,783,710 4,146,829
 Long-term debt 5,036,164 0
Warrant derivative liability 25,992 93,981
Total liabilities 22,501,338 7,635,588
Commitments and contingencies (Note 7)
Stockholders' equity    
Preferred Stock, par value $.0001; 50,000,000 shares authorized; shares issued and outstanding 4,532,664 and 0, respectively as of December 31, 2018 and June 30, 2018 453 0
Common Stock, par value $.0001; 100,000,000 shares authorized; shares issued and outstanding 10,504,769 and 1,794,762, respectively as of December 31, 2018 and June 30, 2018 1,050 179
Additional paid-in capital 107,258,097 92,681,918
Accumulated deficit (87,361,737) (79,257,592)
Total stockholders' equity 19,897,863 13,424,505
Total liabilities and stockholders' equity $ 42,399,201 $ 21,060,093